| Drug Name |
Ioxaglic acid |
| Drug ID |
BADD_D01188 |
| Description |
Ioxaglic acid is marketed as Hexabrix. This drug is an ionic tri-iodinated benzoate used as a low-osmolality contrast agent during diagnostic imaging procedures. Like other organic iodine compounds, ioxaglic acid blocks x-rays and is opaque in its appearance on x-ray film, improving the visualization of important structures and organs during angiography, arteriography, arthrography, cholangiography, urography, and computed tomography [L1889].
Ioxaglic acid has a low osmolarity and is associated with fewer side effects compared to older contrast agents [L1883]. |
| Indications and Usage |
This medicinal product is for diagnostic use only in adults and children as a low-osmolality medium [L1883], [A7924]. |
| Marketing Status |
approved; investigational |
| ATC Code |
V08AB03 |
| DrugBank ID |
DB09313
|
| KEGG ID |
D01761
|
| MeSH ID |
D007485
|
| PubChem ID |
3742
|
| TTD Drug ID |
D0X7IT
|
| NDC Product Code |
Not Available |
| UNII |
Z40X7EI2AF
|
| Synonyms |
Ioxaglic Acid | Ioxaglate Meglumine | Meglumine, Ioxaglate | Methylglucamine Ioxaglate | Ioxaglate, Methylglucamine | Hexabrix | Ioxaglic Acid, Calcium Salt (2:1) | P-286 (Contrast Media) | P286 (Contrast Media) | Ioxaglate | Ioxaglate Sodium | Ioxaglic Acid Monosodium Salt |
